Methodology

All entries for: IPSEN Bioscience Inc.

July 16, 2025

IPSEN Bioscience Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of primary sclerosing cholangitis

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top